In addition, PTPN11 mutations have also been linked to the occurrence of solid tumors (e.g., carcinoma of the lungs, hepatic cell carcinoma, breast, ovarian, gastric, and prostate cancers) [12] and NS [37]. Here, PTPN11 is linked to prostate cancer.